Huibiao Quan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huibiao Quan has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Leweihua Lin
Department of Endocrinology, Hainan General Hospital, Affiliated Hainan Hospital of Hainan Medical University
4 shared publicationsQianying Ou
Department of Endocrinology, Hainan General Hospital, Haikou, China
3 shared publicationsDanhong Lin
Department of Endocrinology, Hainan General Hospital, Affiliated Hainan Hospital of Hainan Medical University
2 shared publicationsZhenshu Gao
Department of Hematology, The second Affiliated Hospital of Hainan Medical University
2 shared publications- Bing Chen
Department of Endocrinology, Southwest Hospital, Third Military Medical University, Chongqing, China
1 shared publication - Bingyin Shi
Department of Endocrinology, First Affiliated Hospital of Xi’an Jiaotong University
1 shared publication
Latest Publications
- Open Access
- 30 October 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1994868
Case Report: Pregnancy-associated fulminant type 1 diabetes superimposed on insulin-treated gestational diabetes with intrauterine fetal demise
Pregnancy-associated fulminant type 1 diabetes (FT1DM) is characterized by abrupt loss of endogenous insulin secretion and rapid progression to diabetic ketoacidosis (DKA). Recognition may be particularly challenging when FT1DM develops in a pregnancy already treated with insulin for gestational diabetes mellitus (GDM), because sudden glycemic deterioration may be attributed to increasing gestational insulin resistance, inadequate insulin dosing, or treatment interruption. We report a 24-year-old woman with insulin-treated GDM who developed dizziness, nausea, and vomiting at 33 weeks of gestation after one scheduled basal insulin dose was omitted. At a referring hospital, plasma glucose was 19.14 mmol/L (345 mg/dL) and urinary ketones were 3 +. Fetal cardiac activity was reportedly present initially but was absent the following day, when intrauterine fetal demise was confirmed. After transfer, plasma glucose was 20.77 mmol/L (374 mg/dL), beta-hydroxybutyrate 6.63 mmol/L (69.0 mg/dL), arterial pH was 7.235, and bicarbonate was 6.00 mmol/L (6.00 mEq/L), confirming persistent severe DKA; glycated hemoglobin was 6.1% (43 mmol/mol). Fasting and stimulated C-peptide concentrations remained profoundly reduced after metabolic stabilization, supporting the diagnosis of pregnancy-associated FT1DM. DKA improved with intravenous fluids, insulin, electrolyte replacement, and close biochemical monitoring, after which labor was induced and a stillborn female fetus was delivered. Repeated glucose and C-peptide measurements during long-term follow-up demonstrated persistent near-complete endogenous insulin deficiency. This case highlights the risk of diagnostic anchoring in insulin-treated GDM. Abrupt gastrointestinal symptoms or unexpected glycemic deterioration should prompt immediate assessment for ketosis and acidosis rather than being attributed solely to gestational insulin resistance or an isolated interruption of insulin treatment.
- 30 October 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1994868
Open AccessCase Report: Pregnancy-associated fulminant type 1 diabetes superimposed on insulin-treated gestational diabetes with intrauterine fetal demise
Pregnancy-associated fulminant type 1 diabetes (FT1DM) is characterized by abrupt loss of endogenous insulin secretion and rapid progression to diabetic ketoacidosis (DKA). Recognition may be particularly challenging when FT1DM develops in a pregnancy already treated with insulin for gestational diabetes mellitus (GDM), because sudden glycemic deterioration may be attributed to increasing gestational insulin resistance, inadequate insulin dosing, or treatment interruption. We report a 24-year-old woman with insulin-treated GDM who developed dizziness, nausea, and vomiting at 33 weeks of gestation after one scheduled basal insulin dose was omitted. At a referring hospital, plasma glucose was 19.14 mmol/L (345 mg/dL) and urinary ketones were 3 +. Fetal cardiac activity was reportedly present initially but was absent the following day, when intrauterine fetal demise was confirmed. After transfer, plasma glucose was 20.77 mmol/L (374 mg/dL), beta-hydroxybutyrate 6.63 mmol/L (69.0 mg/dL), arterial pH was 7.235, and bicarbonate was 6.00 mmol/L (6.00 mEq/L), confirming persistent severe DKA; glycated hemoglobin was 6.1% (43 mmol/mol). Fasting and stimulated C-peptide concentrations remained profoundly reduced after metabolic stabilization, supporting the diagnosis of pregnancy-associated FT1DM. DKA improved with intravenous fluids, insulin, electrolyte replacement, and close biochemical monitoring, after which labor was induced and a stillborn female fetus was delivered. Repeated glucose and C-peptide measurements during long-term follow-up demonstrated persistent near-complete endogenous insulin deficiency. This case highlights the risk of diagnostic anchoring in insulin-treated GDM. Abrupt gastrointestinal symptoms or unexpected glycemic deterioration should prompt immediate assessment for ketosis and acidosis rather than being attributed solely to gestational insulin resistance or an isolated interruption of insulin treatment.
- Open Access
- 2 February 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1334893
Genome-wide association study of blood lipid levels in Southern Han Chinese adults with prediabetes
Background: Dyslipidemia is highly prevalent among individuals with prediabetes, further exacerbating their cardiovascular risk. However, the genetic determinants underlying diabetic dyslipidemia in Southern Han Chinese remain largely unexplored.Methods: We performed a genome-wide association study (GWAS) of blood lipid traits in 451 Southern Han Chinese adults with prediabetes. Fasting plasma lipids, including triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were assayed. Genotyping was conducted using the Precision Medicine Diversity Array and Gene Titan platform, followed by genotype imputation using IMPUTE2 with the 1000 Genomes Project (Phase 3, Southern Han Chinese) as reference. Single nucleotide polymorphisms (SNPs) associated with lipid levels were identified using mixed linear regression, with adjustment for covariates.Results: We identified 58, 215, 74 and 81 novel SNPs associated with TG, TC, HDL-C and LDL-C levels, respectively (P < 5×10-5). Several implicated loci were located in or near genes involved in lipid metabolism, including SRD5A2, PCSK7, PITPNC1, IRX3, BPI, and LBP. Pathway enrichment analysis highlighted lipid metabolism and insulin secretion.Conclusion: This first GWAS of dyslipidemia in Southern Han Chinese with prediabetes identified novel genetic variants associated with lipid traits. Our findings provide new insights into genetic mechanisms underlying heightened cardiovascular risk in the prediabetic stage. Functional characterization of implicated loci is warranted.
- 2 February 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1334893
Open AccessGenome-wide association study of blood lipid levels in Southern Han Chinese adults with prediabetes
Background: Dyslipidemia is highly prevalent among individuals with prediabetes, further exacerbating their cardiovascular risk. However, the genetic determinants underlying diabetic dyslipidemia in Southern Han Chinese remain largely unexplored.Methods: We performed a genome-wide association study (GWAS) of blood lipid traits in 451 Southern Han Chinese adults with prediabetes. Fasting plasma lipids, including triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were assayed. Genotyping was conducted using the Precision Medicine Diversity Array and Gene Titan platform, followed by genotype imputation using IMPUTE2 with the 1000 Genomes Project (Phase 3, Southern Han Chinese) as reference. Single nucleotide polymorphisms (SNPs) associated with lipid levels were identified using mixed linear regression, with adjustment for covariates.Results: We identified 58, 215, 74 and 81 novel SNPs associated with TG, TC, HDL-C and LDL-C levels, respectively (P < 5×10-5). Several implicated loci were located in or near genes involved in lipid metabolism, including SRD5A2, PCSK7, PITPNC1, IRX3, BPI, and LBP. Pathway enrichment analysis highlighted lipid metabolism and insulin secretion.Conclusion: This first GWAS of dyslipidemia in Southern Han Chinese with prediabetes identified novel genetic variants associated with lipid traits. Our findings provide new insights into genetic mechanisms underlying heightened cardiovascular risk in the prediabetic stage. Functional characterization of implicated loci is warranted.
- Open Access
- 27 September 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-13
MRPS6 modulates glucose-stimulated insulin secretion in mouse islet cells through mitochondrial unfolded protein response
Lack of efficient insulin secretion from the pancreas can lead to impaired glucose tolerance (IGT), prediabetes, and diabetes. We have previously identified two IGT-associated single nucleotide polymorphisms (SNPs) rs62212118 and rs13052524 located at two overlapping genes: MRPS6 and SLC5A3. In this study, we show that MRPS6 but not SLC5A3 regulates glucose-stimulated insulin secretion (GSIS) in primary human β-cell and a mouse pancreatic insulinoma β-cell line. Data mining and biochemical studies reveal that MRPS6 is positively regulated by the mitochondrial unfolded protein response (UPRmt), but feedback inhibits UPRmt. Disruption of such feedback by MRPS6 knockdown causes UPRmt hyperactivation in high glucose conditions, hence elevated ROS levels, increased apoptosis, and impaired GSIS. Conversely, MRPS6 overexpression reduces UPRmt, mitigates high glucose-induced ROS levels and apoptosis, and enhances GSIS in an ATF5-dependent manner. Consistently, UPRmt up-regulation or down-regulation by modulating ATF5 expression is sufficient to decrease or increase GSIS. The negative role of UPRmt in GSIS is further supported by analysis of public transcriptomic data from murine islets. In all, our studies identify MRPS6 and UPRmt as novel modulators of GSIS and apoptosis in β-cells, contributing to our understanding of the molecular and cellular mechanisms of IGT, prediabetes, and diabetes.
- 27 September 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-13
Open AccessMRPS6 modulates glucose-stimulated insulin secretion in mouse islet cells through mitochondrial unfolded protein response
Lack of efficient insulin secretion from the pancreas can lead to impaired glucose tolerance (IGT), prediabetes, and diabetes. We have previously identified two IGT-associated single nucleotide polymorphisms (SNPs) rs62212118 and rs13052524 located at two overlapping genes: MRPS6 and SLC5A3. In this study, we show that MRPS6 but not SLC5A3 regulates glucose-stimulated insulin secretion (GSIS) in primary human β-cell and a mouse pancreatic insulinoma β-cell line. Data mining and biochemical studies reveal that MRPS6 is positively regulated by the mitochondrial unfolded protein response (UPRmt), but feedback inhibits UPRmt. Disruption of such feedback by MRPS6 knockdown causes UPRmt hyperactivation in high glucose conditions, hence elevated ROS levels, increased apoptosis, and impaired GSIS. Conversely, MRPS6 overexpression reduces UPRmt, mitigates high glucose-induced ROS levels and apoptosis, and enhances GSIS in an ATF5-dependent manner. Consistently, UPRmt up-regulation or down-regulation by modulating ATF5 expression is sufficient to decrease or increase GSIS. The negative role of UPRmt in GSIS is further supported by analysis of public transcriptomic data from murine islets. In all, our studies identify MRPS6 and UPRmt as novel modulators of GSIS and apoptosis in β-cells, contributing to our understanding of the molecular and cellular mechanisms of IGT, prediabetes, and diabetes.
- Open Access
- 9 July 2022
- Published by Wiley in International Journal of Endocrinology
- Vol. 2022, 1-11
An Investigation on the Risk Factors of Thyroid Diseases in Community Population in Hainan
Background. In recent years, the incidence of thyroid diseases has increased significantly, which has seriously affected people's work and life. The purpose of this study was to explore the epidemiological characteristics of thyroid diseases and autoantibodies. Method. According to the principle of overall sampling, resident residents 18 years and who will not move within 5 years are randomly selected. A total of 2136 eligible individuals were divided into case and control groups according to whether they have thyroid disease. Finally, the impact of potential risk factors on thyroid diseases was evaluated. Results. The overall prevalence of thyroid disease was 58.3, and there was a significant difference in the prevalence of thyroid disease between women and men (p=0.004). Except for the age group 70 years, with the increase in age, the prevalence gradually increased (ppp=0.004) and free thyroid hormone (FT4) (p=0.001) levels of men were higher than those of women, and the TSH level of women was higher than that of men (p=0.002). The regression analysis showed that women, older age, and family history of thyroid disease were independent risk factors for thyroid disease. Conclusion. The prevalence of thyroid diseases in Hainan was high. Women are more susceptible to thyroid disease than men, and the prevalence increased with age.
- 9 July 2022
- Published by Wiley in International Journal of Endocrinology
- Vol. 2022, 1-11
Open AccessAn Investigation on the Risk Factors of Thyroid Diseases in Community Population in Hainan
Background. In recent years, the incidence of thyroid diseases has increased significantly, which has seriously affected people's work and life. The purpose of this study was to explore the epidemiological characteristics of thyroid diseases and autoantibodies. Method. According to the principle of overall sampling, resident residents 18 years and who will not move within 5 years are randomly selected. A total of 2136 eligible individuals were divided into case and control groups according to whether they have thyroid disease. Finally, the impact of potential risk factors on thyroid diseases was evaluated. Results. The overall prevalence of thyroid disease was 58.3, and there was a significant difference in the prevalence of thyroid disease between women and men (p=0.004). Except for the age group 70 years, with the increase in age, the prevalence gradually increased (ppp=0.004) and free thyroid hormone (FT4) (p=0.001) levels of men were higher than those of women, and the TSH level of women was higher than that of men (p=0.002). The regression analysis showed that women, older age, and family history of thyroid disease were independent risk factors for thyroid disease. Conclusion. The prevalence of thyroid diseases in Hainan was high. Women are more susceptible to thyroid disease than men, and the prevalence increased with age.
- Open Access
- 15 March 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Type 2 diabetes is more predictable in women than men by multiple anthropometric and biochemical measures
Men and women are sexually dimorphic but whether common anthropometric and biochemical parameters predict type 2 diabetes (T2D) in different ways has not been well studied. Here we recruit 1579 participants in Hainan Province, China, and group them by sex. We compared the prediction power of common parameters of T2D in two sexes by association, regression, and Receiver Operating Characteristic (ROC) analysis. HbA1c is associated with FPG stronger in women than in men and the regression coefficient is higher, consistent with higher prediction power for T2D. Age, waist circumference, BMI, systolic and diastolic blood pressure, triglyceride levels, total cholesterol, LDL, HDL, fasting insulin, and proinsulin levels all predict T2D better in women. Except for diastolic blood pressure, all parameters associate or tend to associate with FPG stronger in women than in men. Except for diastolic blood pressure and fasting proinsulin, all parameters associate or tend to associate with HbA1c stronger in women than in men. Except for fasting proinsulin and HDL, the regression coefficients of all parameters with FPG and HbA1c were higher in women than in men. Together, by the above anthropometric and biochemical measures, T2D is more readily predicted in women than men, suggesting the importance of sex-based subgroup analysis in T2D research.
- 15 March 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Open AccessType 2 diabetes is more predictable in women than men by multiple anthropometric and biochemical measures
Men and women are sexually dimorphic but whether common anthropometric and biochemical parameters predict type 2 diabetes (T2D) in different ways has not been well studied. Here we recruit 1579 participants in Hainan Province, China, and group them by sex. We compared the prediction power of common parameters of T2D in two sexes by association, regression, and Receiver Operating Characteristic (ROC) analysis. HbA1c is associated with FPG stronger in women than in men and the regression coefficient is higher, consistent with higher prediction power for T2D. Age, waist circumference, BMI, systolic and diastolic blood pressure, triglyceride levels, total cholesterol, LDL, HDL, fasting insulin, and proinsulin levels all predict T2D better in women. Except for diastolic blood pressure, all parameters associate or tend to associate with FPG stronger in women than in men. Except for diastolic blood pressure and fasting proinsulin, all parameters associate or tend to associate with HbA1c stronger in women than in men. Except for fasting proinsulin and HDL, the regression coefficients of all parameters with FPG and HbA1c were higher in women than in men. Together, by the above anthropometric and biochemical measures, T2D is more readily predicted in women than men, suggesting the importance of sex-based subgroup analysis in T2D research.
- Open Access
- 18 March 2020
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 11, 139
The Presence of Serum TgAb Suggests Lower Risks for Glucose and Lipid Metabolic Disorders in Euthyroid General Population From a National Survey
Purpose: The expressions of antibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) are very common in the sera of patients with autoimmune thyroid diseases (AITD). The relationship between thyroid autoantibodies and the occurrence of glucose and lipid metabolic disorders remains unclear. This study was performed to investigate the correlation between the presence of serum TPOAb/TgAb and those metabolic disorders in euthyroid general population. Methods: The data of this study were derived from the Thyroid Disease, Iodine status, and Diabetes National epidemiological (TIDE) survey from all 31 provinces of mainland China. A total of 17,964 euthyroid subjects including 5,802 males (4,000 with TPOAb−TgAb− and 1,802 with TPOAb+/TgAb+) and 12,162 females (8,000 with TPOAb−TgAb− and 4,162 with TPOAb+/TgAb+) were enrolled in this study. The blood glucose and lipid levels were compared between individuals with TPOAb−TgAb− and those with TPOAb+TgAb−, TPOAb−TgAb+, TPOAb+TgAb+. Results: Both fasting blood glucose (FBG) concentration and the proportion of individuals with impaired FBG (IFG) showed the decreased trends in TPOAb−TgAb+ males as compared with TPOAb−TgAb− men. There were significantly lower FBG and higher HDL-C levels as well as tendencies toward decreased incidences of IGT and hypertriglyceridemia in TPOAb−TgAb+ females when compared with TPOAb−TgAb− women. Binary logistic regression analysis further showed that serum TgAb single positivity in males was an independent protective factor for IFG with an OR of 0.691 (95% CI, 0.503–0.949). For females, serum TgAb single positivity was an independent protective factor for hypertriglyceridemia with an OR of 0.859 (95% CI, 0.748–0.987). Trend test showed that with the increase of serum TgAb level, there were significant decreases in the prevalence of IFG among the men with TSH ≤ 2.5 mIU/L and that of hypertriglyceridemia in the women, especially among non-obese females. Conclusion: Serum TgAb single positivity may imply a reduced risk of IFG in euthyroid men and that of hypertriglyceridemia in euthyroid women. The mechanisms for the independent protective roles of TgAb await further investigation.
- 18 March 2020
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 11, 139
Open AccessThe Presence of Serum TgAb Suggests Lower Risks for Glucose and Lipid Metabolic Disorders in Euthyroid General Population From a National Survey
Purpose: The expressions of antibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) are very common in the sera of patients with autoimmune thyroid diseases (AITD). The relationship between thyroid autoantibodies and the occurrence of glucose and lipid metabolic disorders remains unclear. This study was performed to investigate the correlation between the presence of serum TPOAb/TgAb and those metabolic disorders in euthyroid general population. Methods: The data of this study were derived from the Thyroid Disease, Iodine status, and Diabetes National epidemiological (TIDE) survey from all 31 provinces of mainland China. A total of 17,964 euthyroid subjects including 5,802 males (4,000 with TPOAb−TgAb− and 1,802 with TPOAb+/TgAb+) and 12,162 females (8,000 with TPOAb−TgAb− and 4,162 with TPOAb+/TgAb+) were enrolled in this study. The blood glucose and lipid levels were compared between individuals with TPOAb−TgAb− and those with TPOAb+TgAb−, TPOAb−TgAb+, TPOAb+TgAb+. Results: Both fasting blood glucose (FBG) concentration and the proportion of individuals with impaired FBG (IFG) showed the decreased trends in TPOAb−TgAb+ males as compared with TPOAb−TgAb− men. There were significantly lower FBG and higher HDL-C levels as well as tendencies toward decreased incidences of IGT and hypertriglyceridemia in TPOAb−TgAb+ females when compared with TPOAb−TgAb− women. Binary logistic regression analysis further showed that serum TgAb single positivity in males was an independent protective factor for IFG with an OR of 0.691 (95% CI, 0.503–0.949). For females, serum TgAb single positivity was an independent protective factor for hypertriglyceridemia with an OR of 0.859 (95% CI, 0.748–0.987). Trend test showed that with the increase of serum TgAb level, there were significant decreases in the prevalence of IFG among the men with TSH ≤ 2.5 mIU/L and that of hypertriglyceridemia in the women, especially among non-obese females. Conclusion: Serum TgAb single positivity may imply a reduced risk of IFG in euthyroid men and that of hypertriglyceridemia in euthyroid women. The mechanisms for the independent protective roles of TgAb await further investigation.